keyword
https://read.qxmd.com/read/38467328/fasn-negatively-regulates-p65-expression-by-reducing-its-stability-via-thr-254-phosphorylation-and-isomerization-by-pin1
#21
JOURNAL ARTICLE
Lincoln Barlow, Sophia Josephraj, Boqing Gu, Zizheng Dong, Jian-Ting Zhang
Fatty acid synthase (FASN), the sole cytosolic enzyme responsible for de novo palmitate synthesis in mammalian cells, has been associated with poor prognosis in cancer and shown to cause drug and radiation resistance by upregulating DNA-damage repair via suppression of p65 expression. Targeting FASN by repurposing proton pump inhibitors has generated impressive outcomes in triple negative breast cancer patients. While p65 regulation of DNA damage repair was thought to be due to its suppression of PARP1 gene transcription, the mechanism of FASN regulation of p65 expression was unknown...
March 9, 2024: Journal of Lipid Research
https://read.qxmd.com/read/38451783/activity-of-the-ubiquitin-activating-enzyme-inhibitor-tak-243-in-adrenocortical-carcinoma-acc-cell-lines-patient-derived-organoids-pdos-and-murine-xenografts
#22
JOURNAL ARTICLE
Yashuhiro Arakawa, Ukhyun Jo, Suresh Kumar, Nai-Yun Sun, Fathi Elloumi, Anish Thomas, Nitin Roper, Diana Grace Varghese, Naoko Takebe, Xiaohu Zhang, Michele Ceribelli, David O Holland, Erin Beck, Zina Itkin, Crystal McKnight, Kelli M Wilson, Jameson Travers, Carleen Klumpp-Thomas, Craig J Thomas, Chuong D Hoang, Jonathan M Hernandez, Jaydira Del Rivero, Yves Pommier
Current treatment options for metastatic adrenocortical carcinoma (ACC) have limited efficacy, despite the common use of mitotane and cytotoxic agents. This study aimed to identify novel therapeutic options for ACC. An extensive drug screen was conducted to identify compounds with potential activity against ACC cell lines. We further investigated the mechanism of action of the identified compound, TAK-243, its synergistic effects with current ACC therapeutics, and its efficacy in ACC models including patient-derived organoids and mouse xenografts...
March 7, 2024: Cancer Res Commun
https://read.qxmd.com/read/38447474/deleterious-association-between-proton-pump-inhibitor-and-protein-kinase-inhibitor-exposure-and-survival-for-patients-with-lung-cancer-a-nationwide-cohort-study
#23
JOURNAL ARTICLE
Constance Bordet, Mahmoud Zureik, Yoann Zelmat, Margaux Lafaurie, Maryse Lapeyre-Mestre, Agnès Sommet, Julien Mazieres, Fabien Despas
INTRODUCTION: Previous studies have identified an interaction between protein kinase inhibitors (PKIs) and proton pump inhibitors (PPIs) in patients with lung cancer. This type of interaction may reduce the efficacy of PKIs. However, the effect of PKI-PPI interaction on patient mortality remains controversial. This study set out to determine the impact of PKI-PPI interaction on overall survival for lung cancer patients. MATERIALS AND METHODS: This study was conducted using data from the French National Health Care Database from January 1, 2011 to December 31, 2021...
February 29, 2024: Cancer Treatment and Research Communications
https://read.qxmd.com/read/38439656/control-iq-technology-use-in-individuals-with-high-insulin-requirements-results-from-the-multicenter-higher-iq-trial
#24
JOURNAL ARTICLE
Anders L Carlson, Timothy E Graham, Halis K Akturk, David R Liljenquist, Richard M Bergenstal, Becky Sulik, Viral N Shah, Mark Sulik, Peter Zhao, Peter Briggs, Ravid Sassan-Katchalski, Jordan E Pinsker
BACKGROUND: Control-IQ technology version 1.5 allows for a wider range of weight and total daily insulin (TDI) entry, in addition to other changes to enhance performance for users with high basal rates. This study evaluated the safety and performance of the updated Control-IQ system for users with basal rates >3 units/h and high TDI in a multicenter, single arm, prospective study. METHODS: Adults with type 1 diabetes (T1D) using continuous subcutaneous insulin infusion (CSII) and at least one basal rate over 3 units/h (N = 34, mean age = 39...
March 5, 2024: Journal of Diabetes Science and Technology
https://read.qxmd.com/read/38422177/glycolysis-mediated-activation-of-v-atpase-by-nicotinamide-mononucleotide-ameliorates-lipid-induced-cardiomyopathy-by-repressing-the-cd36-tlr4-axis
#25
JOURNAL ARTICLE
Shujin Wang, Yinying Han, Ruimin Liu, Mengqian Hou, Dietbert Neumann, Jun Zhang, Fang Wang, Yumeng Li, Xueya Zhao, Francesco Schianchi, Chao Dai, Lizhong Liu, Miranda Nabben, Jan F C Glatz, Xin Wu, Xifeng Lu, Xi Li, Joost J F P Luiken
BACKGROUND: Chronic overconsumption of lipids followed by their excessive accumulation in the heart leads to cardiomyopathy. The cause of lipid-induced cardiomyopathy involves a pivotal role for the proton-pump vacuolar-type H+ -ATPase (v-ATPase), which acidifies endosomes, and for lipid-transporter CD36, which is stored in acidified endosomes. During lipid overexposure, an increased influx of lipids into cardiomyocytes is sensed by v-ATPase, which then disassembles, causing endosomal de-acidification and expulsion of stored CD36 from the endosomes toward the sarcolemma...
March 2024: Circulation Research
https://read.qxmd.com/read/38399772/overview-of-ecology-and-aspects-of-antibiotic-resistance-in-campylobacter-spp-isolated-from-free-grazing-chicken-tissues-in-rural-households
#26
JOURNAL ARTICLE
Argyrios Dermatas, Georgios Rozos, Konstantinos Zaralis, Aikaterini Dadamogia, Konstantina Fotou, Eugenia Bezirtzoglou, Konstantoula Akrida-Demertzi, Panagiotis Demertzis, Chrysoula Chrysa Voidarou
Rural households all over the world rear backyard chicken mainly for their own consumption and, to a lesser extent, for barter trade. These chickens represent a staple dish with numerous culinary variations and a cheap source of protein. Although some Campylobacter species, and particularly Campylobacter jejuni and Campylobacter coli , have been associated with industrial poultry carcasses, studies concerning the ecology of this genus in rural households do not exist. To assess the prevalence of Campylobacter species in the tissues of backyard chickens, samples were collected from birds Gallus domesticus bred in households in the rural area of Epirus (Greece), and Campylobacter strains were isolated by quantitative methods at 37 °C and 42 °C...
February 10, 2024: Microorganisms
https://read.qxmd.com/read/38399423/structure-based-in-silico-approaches-reveal-iressa-as-a-multitargeted-breast-cancer-regulatory-signalling-and-receptor-protein-inhibitor
#27
JOURNAL ARTICLE
Hassan Hussain Almasoudi, Mutaib M Mashraqi, Saleh A Alshamrani, Afaf Awwadh Alharthi, Ohud Alsalmi, Mohammed H Nahari, Fares Saeed H Al-Mansour, Abdulfattah Yahya M Alhazmi
Breast cancer begins in the breast cells, mainly impacting women. It starts in the cells that line the milk ducts or lobules responsible for producing milk and can spread to nearby tissues and other body parts. In 2020, around 2.3 million women across the globe received a diagnosis, with an estimated 685,000 deaths. Additionally, 7.8 million women were living with breast cancer, making it the fifth leading cause of cancer-related deaths among women. The mutational changes, overexpression of drug efflux pumps, activation of alternative signalling pathways, tumour microenvironment, and cancer stem cells are causing higher levels of drug resistance, and one of the major solutions is to identify multitargeted drugs...
February 6, 2024: Pharmaceuticals
https://read.qxmd.com/read/38371642/eosinophilic-oesophagitis-in-a-nigerian-adolescent-a-case-report
#28
Ikobah Joanah Moses, Ikwuagwu Elekwachi, Ita Ukpabio, Theophilus Ugbem, Omeodu Chimankpan Okechukwu, Emmanuel Ekanem
Eosinophilic oesophagitis (EoE) is a chronic immune and antigen-mediated disease characterized by symptoms related to oesophageal dysfunction, and histologically, is marked by eosinophilic infiltrate in the oesophageal mucosa. It is prevalent in developed countries and considered rare in developing countries. There is an interplay of allergic and genetic factors in the aetiology of EoE. This is a report of EoE in a 15-year-old female adolescent in Nigeria who presented to the University of Calabar Teaching Hospital with recurrent vomiting, abdominal pain, weight loss, and dysphagia...
2024: Pan African Medical Journal
https://read.qxmd.com/read/38341568/the-anti-staphylococcal-fusidic-acid-as-an-efflux-pump-inhibitor-combined-with-fluconazole-against-vaginal-candidiasis-in-mouse-model
#29
JOURNAL ARTICLE
Salwa E Gomaa, Hisham A Abbas, Fatma A Mohamed, Mohamed A M Ali, Tarek M Ibrahim, Alyaa S Abdel Halim, Mashael A Alghamdi, Basem Mansour, Anis Ahmad Chaudhary, Amr Elkelish, Fehmi Boufahja, Wael A H Hegazy, Fatma Al-Zahraa A Yehia
BACKGROUND: Candida albicans is the most common fungus that causes vaginal candidiasis in immunocompetent women and catastrophic infections in immunocompromised patients. The treatment of such infections is hindered due to the increasing emergence of resistance to azoles in C. albicans. New treatment approaches are needed to combat candidiasis especially in the dwindled supply of new effective and safe antifungals. The resistance to azoles is mainly attributed to export of azoles outside the cells by means of the efflux pump that confers cross resistance to all azoles including fluconazole (FLC)...
February 10, 2024: BMC Microbiology
https://read.qxmd.com/read/38339095/the-mechanism-of-tigecycline-resistance-in-acinetobacter-baumannii-under-sub-minimal-inhibitory-concentrations-of-tigecycline
#30
JOURNAL ARTICLE
Cunwei Liu, Jia Liu, Qinghui Lu, Ping Wang, Qinghua Zou
The presence of sub-minimal inhibitory concentration (sub-MIC) antibiotics in our environment is widespread, and their ability to induce antibiotic resistance is inevitable. Acinetobacter baumannii , a pathogen known for its strong ability to acquire antibiotic resistance, has recently shown clinical resistance to the last-line antibiotic tigecycline. To unravel the complex mechanism of A. baumannii drug resistance, we subjected tigecycline-susceptible, -intermediate, and -mildly-resistant strains to successive increases in sub-MIC tigecycline and ultimately obtained tigecycline-resistant strains...
February 2, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38283226/development-of-pharmacophore-models-for-acrb-protein-and-the-identification-of-potential-adjuvant-candidates-for-overcoming-efflux-mediated-colistin-resistance
#31
JOURNAL ARTICLE
Dibyajyoti Uttameswar Behera, Mahendra Gaur, Maheswata Sahoo, Enketeswara Subudhi, Bharat Bhusan Subudhi
Growing multi-drug resistance (MDR) among ESKAPE pathogens is a huge challenge. Increased resistance to last-resort antibiotics, like colistin, has further aggravated this. Efflux is identified as a major route of colistin resistance. So, finding an FDA-approved efflux inhibitor for potential application as an adjuvant to colistin was the primary objective of this study. E. coli -AcrB pump inhibitors and substrates were used to develop and validate the pharmacophoric model. Drugs confirming this pharmacophore were subjected to molecular docking to identify hits for the AcrB binding pocket...
January 25, 2024: RSC medicinal chemistry
https://read.qxmd.com/read/38283082/the-cell-envelope-integrity-protein-homologue-d0y85_rs06240-of-stenotrophomonas-confers-multiantibiotic-resistance
#32
JOURNAL ARTICLE
Chuanqing Zhong, Xiaoqiang Deng, Aihua Jiang, Yayu Liu, Yuanyuan Liu, Jiafang Fu, Guangxiang Cao
BACKGROUND: The potential role of cell envelope integrity proteins in mediating antibiotic resistance is not well understood. In this study, we investigated whether the cell envelope integrity protein D0Y85_RS06240 from the multiantibiotic resistant strain Stenotrophomonas sp. G4 mediates antibiotic resistance. METHODS: Bioinformatics analysis was conducted to identify proteins related to the D0Y85_RS06240 protein. The D0Y85_RS06240 gene was heterologously expressed in Escherichia coli , both antibiotic MICs and the effect of efflux pump inhibitors on antibiotic MICs were determined by the broth microdilution method...
2024: Canadian Journal of Infectious Diseases & Medical Microbiology
https://read.qxmd.com/read/38269224/chronic-use-of-proton-pump-inhibitors-a-potential-link-to-amino-acid-deficiency-and-the-development-of-depression
#33
Jeevan J Murthy, Sarah Hughes, Colin Travis, Ankit Chalia, Samira Khan, Michael Ang-Rabanes, Raja Mogallapu
In recent years, the gut-brain axis (GBA) has been implicated in several vital physiological processes, including digestion, immunity, inflammation, and mood regulation. Disruption of this network is tied to the development of several pathological conditions, including mood disorders, inflammatory bowel diseases, and dementia. Proton pump inhibitors (PPI) are among the most utilized and easily accessible medications worldwide. Although they are effective at treating conditions, including gastroesophageal reflux disorder (GERD), peptic ulcer disease, Zollinger-Ellison syndrome, and erosive esophagitis, PPIs have several mechanisms that may precipitate protein and, thus, amino acid malnutrition...
December 2023: Curēus
https://read.qxmd.com/read/38260587/structures-of-the-essential-efflux-pump-efpa-from-mycobacterium-tuberculosis-reveal-the-mechanisms-of-substrate-transport-and-small-molecule-inhibition
#34
Shuhui Wang, Kun Wang, Kangkang Song, Pengfei Li, Dongying Li, Yajie Sun, Ye Mei, Chen Xu, Maofu Liao
As the first identified multidrug efflux pump in Mycobacterium tuberculosis ( Mtb ), EfpA is an essential protein and promising drug target. However, the functional and inhibitory mechanisms of EfpA are poorly understood. Herein we report cryo-EM structures of EfpA in outward-open conformation, either bound to three endogenous lipids or the inhibitor BRD-8000.3. Three lipids inside EfpA span from the inner leaflet to the outer leaflet of the membrane. BRD-8000.3 occupies one lipid site at the level of inner membrane leaflet, competitively inhibiting lipid binding...
January 5, 2024: Research Square
https://read.qxmd.com/read/38254714/molecular-modeling-studies-to-probe-the-binding-hypothesis-of-novel-lead-compounds-against-multidrug-resistance-protein-abcb1
#35
JOURNAL ARTICLE
Yasmeen Cheema, Kenneth J Linton, Ishrat Jabeen
The expression of drug efflux pump ABCB1/P-glycoprotein (P-gp), a transmembrane protein belonging to the ATP-binding cassette superfamily, is a leading cause of multidrug resistance (MDR). We previously curated a dataset of structurally diverse and selective inhibitors of ABCB1 to develop a pharmacophore model that was used to identify four novel compounds, which we showed to be potent and efficacious inhibitors of ABCB1. Here, we dock the inhibitors into a model structure of the human transporter and use molecular dynamics (MD) simulations to report the conformational dynamics of human ABCB1 induced by the binding of the inhibitors...
January 16, 2024: Biomolecules
https://read.qxmd.com/read/38248315/identification-of-aly1-and-aly2-as-modulators-of-cytoplasmic-ph-in-saccharomyces-cerevisiae
#36
JOURNAL ARTICLE
Guoyong Liu, Xiuli Han, Xiang Yu, Yu Wang, Jinbiao Ma, Yongqing Yang
The regulation of intracellular pH in yeast ( Saccharomyces cerevisiae ) cells is critical for cell function and viability. In yeast, protons (H+ ) can be excreted from the cell by plasma membrane ATPase PMA1 and pumped into vacuoles by vacuolar H+ -ATPase. Because PMA1 is critical to the survival of yeast cells, it is unknown whether other compensatory components are involved in pH homeostasis in the absence of PMA1. To elucidate how intracellular pH is regulated independently of PMA1, we employed a screening approach by exposing the yeast haploid deletion mutant library (ver 4...
December 25, 2023: Current Issues in Molecular Biology
https://read.qxmd.com/read/38244190/use-of-pharmacokinetic-and-pharmacodynamic-data-to-develop-the-cdk4-6-inhibitor-ribociclib-for-patients-with-advanced-breast-cancer
#37
REVIEW
Yan Ji, Hilmar Schiller, Shu Yang, Michelle Quinlan, Christelle Darstein, Felix Huth, Serge Winter, Abhijit Chakraborty
Ribociclib is an orally bioavailable, selective cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor. CDK4/6 inhibition by ribociclib leads to retinoblastoma tumor suppressor protein (Rb) reactivation, thereby restoring Rb-mediated cell cycle arrest. Ribociclib is approved for the treatment of patients with hormone receptor-positive/human epidermal growth factor receptor-2-negative (HR+/HER2-) advanced breast cancer (ABC), at the dose of 600 mg once daily (QD) during cycles of 21 days on/7 days off, with optional dose reduction to 400 mg and 200 mg...
January 20, 2024: Clinical Pharmacokinetics
https://read.qxmd.com/read/38236777/glutathione-dependent-depalmitoylation-of-phospholemman-by-peroxiredoxin-6
#38
JOURNAL ARTICLE
Jacqueline Howie, Lindsay B Tulloch, Elaine Brown, Louise Reilly, Fiona B Ashford, Jennifer Kennedy, Krzysztof J Wypijewski, Karen L Aughton, Jason K C Mak, Michael J Shattock, Niall J Fraser, William Fuller
Phospholemman (PLM) regulates the cardiac sodium pump: PLM phosphorylation activates the pump whereas PLM palmitoylation inhibits its activity. Here, we show that the anti-oxidant protein peroxiredoxin 6 (Prdx6) interacts with and depalmitoylates PLM in a glutathione-dependent manner. Glutathione loading cells acutely reduce PLM palmitoylation; glutathione depletion significantly increases PLM palmitoylation. Prdx6 silencing abolishes these effects, suggesting that PLM can be depalmitoylated by reduced Prdx6...
January 17, 2024: Cell Reports
https://read.qxmd.com/read/38230441/unveiling-the-potential-of-recently-fda-approved-drugs-as-quorum-sensing-inhibitors-against-p-aeruginosa-using-high-performance-computational-techniques
#39
JOURNAL ARTICLE
Debanjan Dey, Anoop Kumar
Through cell-to-cell communication, activation of efflux pumps, formation of biofilms, and other mechanisms, pseudomonas aeruginosa's quorum sensing systems (QSS), notably the lasl/las-r system, contribute a vital role in the development of anti-microbial resistance (AMR). Identifying potential drugs against these targets could have significant implications for combating pseudomonal infections. The current study aims to identify promising recently FDA-approved drugs against lasl/las-r proteins. The ligands were selected from the FDA-approved drug lists of the last 5 years...
January 17, 2024: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38214500/inhibition-of-polymorphic-mexxy-oprm-efflux-system-in-pseudomonas-aeruginosa-clinical-isolates-by-berberine-derivatives
#40
JOURNAL ARTICLE
Giorgia Giorgini, Alessandra Di Gregorio, Gianmarco Mangiaterra, Nicholas Cedraro, Cristina Minnelli, Giulia Sabbatini, Giovanna Mobbili, Serena Simoni, Carla Vignaroli, Roberta Galeazzi
The MexXY-OprM multidrug efflux pump (EP) in aminoglycosides resistant Pseudomonas aeruginosa is one of the major resistance mechanisms, which is often overexpressed in strains isolated from pulmonary chronic disease such as cystic fibrosis [1-3]. In this research, we focused on the design of potential efflux pumps inhibitors, targeting MexY, the inner membrane component, in an allosteric site. Berberine [4] has been considered as lead molecule since we previously demonstrated its effectiveness in targeting MexY in laboratory reference strains [5,6]...
January 12, 2024: ChemMedChem
keyword
keyword
30249
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.